Quick Search

 

 


 

 

Result Summary for 112795

Result Summary
Protocol ID: 112795
Clinical Study ID: HMA112795
Official Title: A two part, multicenter Phase IIa, placebo controlled study, to examine the safety, tolerability, and effects of GSK256073 on lipids in subjects with dyslipidemia
Phase: phase 2
Study Indications or Diseases:
  • Dyslipidaemias
Generic Name: GSK256073
Trade/Product Name: GSK256073
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.